MLEC
Moolec Science SA Ordinary Shares
NASDAQ: MLEC · HEALTHCARE · BIOTECHNOLOGY
$11.25
+25.14% today
Updated 2026-04-30
Market cap
$5.87M
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-258.69
Dividend yield
—
52W range
$3 – $157
Volume
0.4M
Moolec Science SA Ordinary Shares (MLEC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $905049.00 | $5.63M | $333.61M |
| Revenue growth (YoY) | — | — | — | +521.5% | +5830.7% |
| Cost of revenue | — | $0.00 | $1.05M | $5.15M | $219.61M |
| Gross profit | — | $0.00 | $-143305.00 | $472581.00 | $114.01M |
| Gross margin | — | — | -15.8% | 8.4% | 34.2% |
| R&D | — | $985158.00 | $1.35M | $1.77M | $9.24M |
| SG&A | — | $2.52M | $47.42M | $6.54M | $88.83M |
| Operating income | $-13800.00 | $-1.72M | $-6.65M | $-9.04M | $-10.48M |
| Operating margin | — | — | -735.2% | -160.8% | -3.1% |
| EBITDA | $-13800.00 | $-3.65M | $-51.74M | $-6.16M | $-69.01M |
| EBITDA margin | — | — | -5717.0% | -109.5% | -20.7% |
| EBIT | $-220097.00 | $-3.65M | $-51.86M | $-7.17M | $-91.27M |
| Interest expense | — | $2130.00 | $160035.00 | $1.17M | $41.81M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13802.00 | $-4.53M | $-51.79M | $-7.31M | $-111.46M |
| Net income growth (YoY) | — | -32698.9% | -1044.0% | +85.9% | -1424.3% |
| Profit margin | — | — | -5722.2% | -130.0% | -33.4% |